Literature DB >> 29434970

The expression and underlying angiogenesis effect of DPC4 and VEGF on the progression of cervical carcinoma.

Yanni A1, Ying Li2, Shuping Zhao3.   

Abstract

The present study aimed to investigate the expression and roles of deleted in pancreatic carcinoma locus 4 (DPC4) and vascular endothelial growth factor (VEGF) in the development of cervical carcinoma. A total of 115 patients aged between 25 and 60 years were involved, including 19 cervical inflammation, 35 cervical intraepithelial neoplasia (CIN), and 61 cervical squamous-cell carcinoma (CSCC). The protein expression rates of DPC4 and VEGF in all samples were detected using immunohistochemistry. The protein levels of DPC4 and VEGF in CSCC samples were measured using ELISA. Microvessel density (MVD) of each CSCC sample was measured according to the Winder method. Association analysis between DPC4, VEGF and thrombospondin-1 (TSP-1) was conducted using Spearman's correlations. The negative expression rate of DPC4 [DPC4 (-)] and positive expression rate of VEGF [VEGF (+)] of the CSCC group were significantly higher compared with that in the cervical inflammation and CIN groups (P<0.05). In the CSCC group, the protein level of DPC4 decreased, while the VEGF level increased significantly compared with the healthy control group (P<0.05). The MVD in the DPC4 (-), VEGF (+) and TSP-1 (-) groups was significantly increased compared with that of the DPC4 (+), VEGF (-), and TSP-1 (+) groups (P<0.05). The expression of DPC4 was negatively associated with VEGF and TSP-1 (P<0.01). These results suggest that DPC4, VEGF and TSP-1 are involved in the carcinogenesis of cervical carcinoma by inducing angiogenesis. In addition, the loss of DPC4 induces angiogenesis through increasing VEGF. Thus, VEGF may be a target gene regulated by DPC4.

Entities:  

Keywords:  angiogenesis; cervical carcinoma; deleted in pancreatic carcinoma locus 4; vascular endothelial growth factor

Year:  2017        PMID: 29434970      PMCID: PMC5777235          DOI: 10.3892/ol.2017.7580

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma.

Authors:  Yinmei Dai; Xiangdong Zhang; Yunhua Peng; Ziren Wang
Journal:  Gynecol Oncol       Date:  2005-04       Impact factor: 5.482

2.  Thrombospondin-1 and -2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis.

Authors:  J Kodama; I Hashimoto; N Seki; A Hongo; M Yoshinouchi; H Okuda; T Kudo
Journal:  Clin Cancer Res       Date:  2001-09       Impact factor: 12.531

3.  Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.

Authors:  S A Hahn; D Bartsch; A Schroers; H Galehdari; M Becker; A Ramaswamy; I Schwarte-Waldhoff; H Maschek; W Schmiegel
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

4.  Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer.

Authors:  Sharyn N Lewin; Thomas J Herzog; Nicanor I Barrena Medel; Israel Deutsch; William M Burke; Xuming Sun; Jason D Wright
Journal:  Obstet Gynecol       Date:  2010-11       Impact factor: 7.661

5.  Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.

Authors:  D Bartsch; S A Hahn; K D Danichevski; A Ramaswamy; D Bastian; H Galehdari; P Barth; W Schmiegel; B Simon; M Rothmund
Journal:  Oncogene       Date:  1999-04-08       Impact factor: 9.867

6.  Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients.

Authors:  A A Alvarez; J R Axelrod; R S Whitaker; P D Isner; R C Bentley; R K Dodge; G C Rodriguez
Journal:  Gynecol Oncol       Date:  2001-08       Impact factor: 5.482

Review 7.  Regulation of tumor angiogenesis by thrombospondin-1.

Authors:  Bin Ren; Karen O Yee; Jack Lawler; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2005-12-21

8.  Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.

Authors:  Xuemei Li; Baoquan Liu; Jianbing Xiao; Ying Yuan; Jing Ma; Yafang Zhang
Journal:  J Gastrointest Surg       Date:  2011-07-23       Impact factor: 3.452

9.  Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis.

Authors:  Philippe O Van Trappen; Dawn Steele; David G Lowe; Suhail Baithun; Nigel Beasley; Wilko Thiele; Herbert Weich; Jaya Krishnan; John H Shepherd; Michael S Pepper; David G Jackson; Jonathan P Sleeman; Ian J Jacobs
Journal:  J Pathol       Date:  2003-12       Impact factor: 7.996

10.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

Authors:  K M Dameron; O V Volpert; M A Tainsky; N Bouck
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

View more
  1 in total

Review 1.  Cervical Carcinoma: Oncobiology and Biomarkers.

Authors:  Larisa V Volkova; Alexander I Pashov; Nadezhda N Omelchuk
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.